348 related articles for article (PubMed ID: 31046780)
1. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
[TBL] [Abstract][Full Text] [Related]
2. Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy.
Choudhary P; Nandakumar R; Greig H; Broadhurst P; Dean J; Puranik R; Celermajer DS; Hillis GS
Heart; 2016 Sep; 102(18):1472-8. PubMed ID: 27164920
[TBL] [Abstract][Full Text] [Related]
3. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.
Muehlberg F; Arnhold K; Fritschi S; Funk S; Prothmann M; Kermer J; Zange L; von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
J Cardiovasc Magn Reson; 2018 Feb; 20(1):13. PubMed ID: 29458430
[TBL] [Abstract][Full Text] [Related]
5. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD
Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096
[TBL] [Abstract][Full Text] [Related]
6. Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study.
Blaszczyk E; Lim C; Kellman P; Schmacht L; Gröschel J; Spuler S; Schulz-Menger J
J Cardiovasc Magn Reson; 2021 Nov; 23(1):130. PubMed ID: 34743704
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.
Schmacht L; Traber J; Grieben U; Utz W; Dieringer MA; Kellman P; Blaszczyk E; von Knobelsdorff-Brenkenhoff F; Spuler S; Schulz-Menger J
Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27363857
[TBL] [Abstract][Full Text] [Related]
8. Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study.
Petri H; Ahtarovski KA; Vejlstrup N; Vissing J; Witting N; Køber L; Bundgaard H
J Cardiovasc Magn Reson; 2014 Aug; 16(1):59. PubMed ID: 25086734
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.
Chmielewski L; Bietenbeck M; Patrascu A; Rösch S; Sechtem U; Yilmaz A; Florian AR
Clin Res Cardiol; 2019 Aug; 108(8):857-867. PubMed ID: 30767060
[TBL] [Abstract][Full Text] [Related]
10. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
11. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.
Raucci FJ; Xu M; George-Durrett K; Crum K; Slaughter JC; Parra DA; Markham LW; Soslow JH
J Cardiovasc Magn Reson; 2021 Apr; 23(1):48. PubMed ID: 33910579
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
[TBL] [Abstract][Full Text] [Related]
13. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.
Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC
J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686
[TBL] [Abstract][Full Text] [Related]
15. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I.
Rosales XQ; Moser SJ; Tran T; McCarthy B; Dunn N; Habib P; Simonetti OP; Mendell JR; Raman SV
J Cardiovasc Magn Reson; 2011 Aug; 13(1):39. PubMed ID: 21816046
[TBL] [Abstract][Full Text] [Related]
17. Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy.
Leali M; Aimo A; Ricci G; Torri F; Todiere G; Vergaro G; Grigoratos C; Giannoni A; Aquaro GD; Siciliano G; Emdin M; Passino C; Barison A
J Cardiovasc Med (Hagerstown); 2023 Jun; 24(6):340-347. PubMed ID: 37129928
[TBL] [Abstract][Full Text] [Related]
18. Deactivation vs. asynchronous pacing - prospective evaluation of a protocol for rhythm management in patients with magnetic resonance conditional pacemakers undergoing adenosine stress cardiovascular magnetic resonance imaging.
Klein-Wiele O; Garmer M; Barbone G; Urbien R; Busch M; Kara K; Schäfer H; Schulte-Hermes M; Hailer B; Grönemeyer D
BMC Cardiovasc Disord; 2017 Jun; 17(1):142. PubMed ID: 28577544
[TBL] [Abstract][Full Text] [Related]
19. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.
Hor KN; Taylor MD; Al-Khalidi HR; Cripe LH; Raman SV; Jefferies JL; O'Donnell R; Benson DW; Mazur W
J Cardiovasc Magn Reson; 2013 Dec; 15(1):107. PubMed ID: 24359596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
